Drug reference
pentoxiphylline
Phosphodiesterase inhibitor, Rheologic agent · Peripheral vasodilator
Phosphodiesterase inhibitor, Rheologic agentPeripheral vasodilator
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
—
none in our sources
PREGNANCY
—
not curated
Mechanism
Weak phosphodiesterase (PDE) inhibitor. Increases blood flow in ischaemic areas by reducing whole blood viscosity and by improving flexibility of RBCs (rheological action).
Indications
Intermittent claudication (due to occlusive vascular disease like Buerger’s disease)Trophic leg ulcersTransient ischaemic attacks (TIAs)Nonhaemorrhagic strokeChronic cerebrovascular insufficiency
Dosing
- Adult
- 400 mg BD–TDS
Side effects
Common
nauseavomitingdyspepsiabloating
Related guidelines
Ask House about pentoxiphylline
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: KD Tripathi 7e·Verified: 2026-05-10 · House clinical team